TMPRSS4 and neoplasm: The next step was to quantify the methylation status of the TMPRSS4 promoter by ddPCR in tumor samples from NSCLC patients, in order to validate our previous results using pyrosequencing and 450k arrays, which showed hypomethylation of cg25116503 in tumors.